Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine.
about
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL)A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.Cancer stem cells of differentiated B-cell malignancies: models and consequences.Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment.B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells.Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia.
P2860
Q34374056-6B13FF7F-9363-40FA-B4A4-3A82FF735680Q35951131-9CBE3192-E7C2-4E39-83B2-D564FC72C577Q36016148-54C7D00B-003C-4B52-A97A-69BDF8B4C1B8Q37876363-ED538035-E7A7-4D7F-9809-EAD25093D7A2Q38161351-8A604D36-53F2-43B8-8CBD-9DFD8E2178DAQ42355445-C95FA0AD-748C-46DB-BAB5-148D5716B3C3Q42912844-9A6BE5FB-C469-4E9B-98D1-4719CFF8A841Q50958025-BD78C0E6-99D0-44D4-A7C4-A0B3E63A4B5F
P2860
Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Selective elimination of a che ...... ous hCD40L/IL-2 tumor vaccine.
@ast
Selective elimination of a che ...... ous hCD40L/IL-2 tumor vaccine.
@en
type
label
Selective elimination of a che ...... ous hCD40L/IL-2 tumor vaccine.
@ast
Selective elimination of a che ...... ous hCD40L/IL-2 tumor vaccine.
@en
prefLabel
Selective elimination of a che ...... ous hCD40L/IL-2 tumor vaccine.
@ast
Selective elimination of a che ...... ous hCD40L/IL-2 tumor vaccine.
@en
P2093
P2860
P356
P1433
P1476
Selective elimination of a che ...... ous hCD40L/IL-2 tumor vaccine.
@en
P2093
A E Foster
H E Heslop
M A Goodell
P2860
P2888
P304
P356
10.1038/LEU.2009.281
P577
2010-01-14T00:00:00Z
P5875
P6179
1032300266